Acalanib 100 Mg (Acalabrutinib)

Description

About Acalanib 100 Mg

Acalabrutinib (INN) 100mg is the active ingredient in each Acalanib tablet. The producer of this medicine is Drug International Pharma. The BTK inhibitor acalabrutinib works by blocking the enzyme’s small-molecule activation. BCR (B-cell antigen receptor) signalling and cytokine receptor signalling both involve BTK. There are 60 tablets of Acalanib 100mg in each bottle. Patients over the age of 18 with Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukaemia (CLL), or Small Lymphocytic Lymphoma (SLL) may benefit from acalanib 100 mg (SLL). This treatment option is only recommended after patients with MCL have tried at least one other therapy first.

Dosage

You can take 100 mg of acalanib twice a day with or without food. It needs to be taken orally, once every 12 hours on average. The most beneficial effects from this medication will occur if you take it exactly as prescribed by your doctor. In the event of an overdose, the patient needs to be watched for any negative side effects. The patient should immediately seek professional medical attention if they experience any adverse reactions.

Side Effects 

• Blood loss.  
• cytopenias. 
• infections. 
• cancers. 
• flutter.

Storage

You should keep your 100mg of acalanib in a cool, dry place that doesn’t get too hot, out of the reach of children, and out of the sun.